CPH •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/24/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeCPH
Market Capitalization1,429,876 mln
Float3,185 mln
Earnings Date08/05/2026
EPS
27.41
Exceptional
P / E
11.78
Fair value
1-Year Forecast
317
Fairly priced
Relative Strength
57
/ 100
Slightly ahead
Debt / Equity
0.72
Moderate leverage
ROE
71.40
Exceptional
Business Description
Founded in 1923 and based in Denmark, Novo Nordisk is a global pharmaceutical company best known for its treatments targeting diabetes and obesity, as well as a range of rare conditions affecting blood, hormones, and growth. The company develops and sells medicines, smart insulin delivery devices, and digital dosing tools, serving patients across North America, Europe, Asia, Latin America, and beyond.
